1. Home
  2. RNA vs MHO Comparison

RNA vs MHO Comparison

Compare RNA & MHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • MHO
  • Stock Information
  • Founded
  • RNA 2012
  • MHO 1976
  • Country
  • RNA United States
  • MHO United States
  • Employees
  • RNA N/A
  • MHO N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • MHO Homebuilding
  • Sector
  • RNA Health Care
  • MHO Consumer Discretionary
  • Exchange
  • RNA Nasdaq
  • MHO Nasdaq
  • Market Cap
  • RNA 3.2B
  • MHO 3.1B
  • IPO Year
  • RNA 2020
  • MHO 1986
  • Fundamental
  • Price
  • RNA $26.66
  • MHO $106.19
  • Analyst Decision
  • RNA Strong Buy
  • MHO Strong Buy
  • Analyst Count
  • RNA 12
  • MHO 3
  • Target Price
  • RNA $68.25
  • MHO $168.00
  • AVG Volume (30 Days)
  • RNA 1.9M
  • MHO 276.3K
  • Earning Date
  • RNA 05-08-2025
  • MHO 04-23-2025
  • Dividend Yield
  • RNA N/A
  • MHO N/A
  • EPS Growth
  • RNA N/A
  • MHO 21.59
  • EPS
  • RNA N/A
  • MHO 19.71
  • Revenue
  • RNA $10,897,000.00
  • MHO $4,504,670,000.00
  • Revenue This Year
  • RNA N/A
  • MHO $7.09
  • Revenue Next Year
  • RNA $135.33
  • MHO $5.18
  • P/E Ratio
  • RNA N/A
  • MHO $5.39
  • Revenue Growth
  • RNA 13.98
  • MHO 11.68
  • 52 Week Low
  • RNA $21.51
  • MHO $100.22
  • 52 Week High
  • RNA $56.00
  • MHO $176.18
  • Technical
  • Relative Strength Index (RSI)
  • RNA 45.21
  • MHO 41.03
  • Support Level
  • RNA $25.28
  • MHO $102.59
  • Resistance Level
  • RNA $27.67
  • MHO $109.01
  • Average True Range (ATR)
  • RNA 2.36
  • MHO 6.03
  • MACD
  • RNA -0.03
  • MHO -0.41
  • Stochastic Oscillator
  • RNA 56.41
  • MHO 36.81

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

About MHO M/I Homes Inc.

M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprise a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.

Share on Social Networks: